Dendritic cells mediate NK cell help for Th1 and CTL responses: Two-signal requirement for the induction of NK cell helper function

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2366-2373

  Mailliard, Robbie B ^a   Son, Young Ik ^a,d   Redlinger, Richard ^a   Coates, Patrick T ^a   Giermasz, Adam ^a   Morel, Penelope A ^b   Storkus, Walter J ^a,b,c   Kalinski, Pawel ^a,b,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL FUNCTION; CELL KILLING; CELL MIGRATION; CELL STRAIN K 562; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY CELL; NATURAL KILLER CELL; TH1 CELL; VIRUS INFECTION;

EID: 0042931206     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2366     Document Type: Article

References (76)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20:561.
3. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199.
4. Liu, Y. J., H. Kanzler, V. Soumelis, and M. Gilliet. 2001. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2:585.
5. Pulendran, B., K. Palucka, and J. Banchereau. 2001. Sensing pathogens and tuning immune responses. Science 293:253.
6. Schulz, O., A. D. Edwards, M. Schito, J. Aliberti, S. Manickasingham, A. Sher, and Reis e Sousa. 2000. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13:453.
7. Sousa, C. R., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819.
8. Pulendran, B., P. Kumar, C. W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau. 2001. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167:5067.
9. Moulin, V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, and M. Moser. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192:475.
10. + T cells in the development of T helper type 1 responses. J. Exp. Med. 195:473.
11. + CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein. J. Immunol. 167:384.
12. Stumbles, P. A., D. H. Strickland, C. L. Pimm, S. F. Proksch, A. M. Marsh, A. S. McWilliam, A. Bosco, I. Tobagus, J. A. Thomas, S. Napoli, et al. 2001. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J. Immunol. 167:228.
13. Lin, C. L., A. K. Sewell, G. F. Gao, K. T. Whelan, R. E. Phillips, and J. M. Austyn. 2000. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192:587.
14. Biron, C. A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24.
15. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405.
16. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343.
17. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:335.
18. Gerosa, F., B. Baldini-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327.
19. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731.
20. Polic, B., H. Hengel, A. Krmpotic, I. Trgovcich, I. Pavic, P. Luccaronin, S. Jonjic, and U. H. Koszinowski. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188:1047.
21. de Vries, E., H. R. Koene, J. M. Vossen, J. W. Gratama, A. E. dem Borne, J. L. Waaijer, A. Haraldsson, M. de Haas, and M. J. van Tol. 1996. Identification of an unusual Fcγ receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood 88:3022.
22. Goodyear, H. M., P. McLeish, S. Randall, A. Buchan, G. R. Skinner, M. Winther, J. Rolland, G. Morgan, and J. I. Harper. 1996. Immunological studies of herpes simplex virus infection in children with atopic eczema. Br. J. Dermatol. 134:85.
23. Cauda, R., V. Laghi, M. Tumbarello, L. Ortona, and R. J. Whitley. 1989. Immunological alterations associated with recurrent herpes simplex genitalis. Clin. Immunol. Immunopathol. 51:294.
24. Hendricks, R. L., and J. Sugar. 1984. Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells. Cell Immunol. 83:262.
25. Hsu, S. M., J. Cossman, and E. S. Jaffe. 1983. Lymphocyte subsets in normal human lymphoid tissues. Am. J. Clin. Pathol. 80:21.
26. Si, L., and T. L. Whiteside. 1983. Tissue distribution of human NK cells studied with anti-Leu-7 monoclonal antibody. J. Immunol. 130:2149.
27. Salazar-Mather, T. P., R. Ishikawa, and C. A. Biron. 1996. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J. Immunol. 157:3054.
28. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
29. Friberg, D. D., J. L. Bryant, and T. L. Whiteside. 1996. Measurements of natural killer (NK) activity and NK-cell quantification. Methods 9:316.
30. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
31. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
32. Shah, P. D., S. M. Gilbertson, and D. A. Rowley. 1985. Dendritic cells that have interacted with antigen are targets for natural killer cells. J. Exp. Med. 162:625.
33. Zheng, C., M. Ostad, M. Andersson, F. Celsing, G. Holm, and A. Sundblad. 2002. Natural cytotoxicity to autologous antigen-pulsed dendritic cells in multiple myeloma. Br. J. Haematol. 118:778.
34. Wilson, J. L., J. Charo, A. Martin-Fontecha, P. Dellabona, G. Casorati, B. J. Chambers, R. Kiessling, M. T. Bejarano, and H. G. Ljunggren. 1999. NK cell triggering by the human costimulatory molecules CD80 and CD86. J. Immunol. 163:4207.
35. Wilson, J. L., L. C. Heffler, J. Charo, A. Scheynius, M. T. Bejarano, and H. G. Ljunggren. 1999. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163:6365.
36. Fitzgerald-Bocarsly, P., M. Feldman, M. Mendelsohn, S. Curl, and C. Lopez. 1988. Human mononuclear cells which produce interferon-α during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. J. Leukocyte Biol. 43:323.
37. +) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus infected fibroblasts but not herpes simplex virus-infected Raji. J. Immunol. 143:1318.
38. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821.
39. Vieira, P. L., E. C. de Jong, E. A. Wierenga, M. L. Kapsenberg, and P. Kalinski. 2000. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164:4507.
40. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147.
41. Snijders, A., C. M. Hilkens, van Der Pouw Kraan, T. C., M. Engel, L. A. Aarden, and M. L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207.
42. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593.
43. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
44. Toellner, K. M., S. A. Luther, D. M. Sze, R. K. Choy, D. R. Taylor, I. C. MacLennan, and H. Acha-Orbea. 1998. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp. Med. 187:1193.
45. Sangster, M. Y., X. Y. Mo, R. Sealy, and C. Coleclough. 1997. Matching anti-body class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation. J. Immunol. 159:1893.
46. Biron, C. A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458.
47. Puoti, M., B. Zanini, R. Bruno, M. Airoldi, S. Rossi, R. E. Quiros, H. El, I., F. Moretti, F. Castelli, P. Sacchi, G. Filice, and G. Carosi. 2002. Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV. HIV Clin. Trials 3:324.
48. Kornberg, A., M. Hommann, A. Tannapfel, T. Wagner, T. Grube, U. Schotte, R. Voigt, and J. Scheele. 2001. Long-term combination of interferon α-2b and ribavirin for hepatitis C recurrence in liver transplant patients. Am. J. Transplant. 1:350.
49. Agarwala, S. S., and J. M. Kirkwood. 1998. Adjuvant therapy of melanoma. Semin. Surg. Oncol. 14:302.
50. Khan, O., R. Zabad, C. Caon, M. Zvartau-Hind, A. Tselis, and R. Lisak. 2002. Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis. CNS Drugs 16:563.
51. Bahner, D., C. Klueke, B. Kitze, E. Elitok, T. Bogumil, A. Dressel, H. Tumani, F. Weber, S. Poser, and A. Bitsch. 2002. Interferon-β-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients. Neurosci. Lett. 326:125.
52. Goodin, D. S. 2001. Interferon-β therapy in multiple sclerosis: evidence for a clinically relevant dose response. Drugs 61:1693.
53. Triantaphyllopoulos, K. A., R. O. Williams, H. Tailor, and Y. Chernajovsky, 1999. Amelioration of collagen-induced arthritis and suppression of interferon-γ, interleukin-12, and tumor necrosis factor α production by interferon-β gene therapy. Arthritis Rheum. 42:90.
54. Rogge, L., D. D'Ambrosio, M. Biffi, G. Penna, L. J. Minetti, D. H. Presky, L. Adorini, and F. Sinigaglia. 1998. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161:6567.
55. Cho, S. S., C. M. Bacon, C. Sudarshan, R. C. Rees, D. Finbloom, R. Pine, and J. J. O'Shea. 1996. Activation of STAT4 by IL-12 and IFN-α: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:4781.
56. Yu, C. R., J. X. Lin, D. W. Fink, S. Akira, E. T. Bloom, and A. Yamauchi. 1996. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-α. J. Immunol. 157:126.
57. Nguyen, K. B., W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien, A. Morinobu, M. Gadina, J. J. O'Shea, and C. A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297:2063.
58. Freudenberg, M. A., T. Merlin, C. Kalis, Y. Chvatchko, H. Stubig, and C. Galanos. 2002. Cutting edge: a murine, IL-12-independent pathway of IFN-γ induction by Gram-negative bacteria based on STAT4 activation by type I IFN and IL-18 signaling. J. Immunol. 169:1665.
59. Sinigaglia, F., D. D'Ambrosio, P. Panina-Bordignon, and L. Rogge. 1999. Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function. Immunol. Rev. 170:65.
60. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634.
61. McRae, B. L., R. T. Semnani, M. P. Hayes, and G. A. van Seventer. 1998. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160:4298.
62. McRae, B. L., B. A. Beilfuss, and G. A. van Seventer. 2000. IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells. J. Immunol. 164:23.
63. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Briere, G. Trinchieri, and C. A. Biron. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517.
64. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835.
65. Raeymaekers, L. 2002. Dynamics of Boolean networks controlled by biologically meaningful functions. J. Theor. Biol. 218:331.
66. Nathan, C. 2002. Points of control in inflammation. Nature 420:846.
67. Arrighi, J. F., M. Rebsamen, F. Rousset, V. Kindler, and C. Hauser. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J. Immunol. 166:3837.
68. - natural killer cells suppress dendritic cells. J. Exp. Med. 163:1012.
69. Doherty, P. C., and J. E. Allan. 1987. Anti-asialo GM1 eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model. Cell Immunol. 107:1.
70. Kelly, J. M., P. K. Darcy, J. L. Markby, D. I. Godfrey, K. Takeda, H. Yagita, and M. J. Smyth. 2002. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3:83.
71. Coudert, J. D., C. Coureau, and J. C. Guery. 2002. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens. J. Immunol. 169:2979.
72. Hussell, T., and P. J. Openshaw. 2000. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J. Immunol. 165:7109.
73. Szomolanyi-Tsuda, E., J. D. Brien, J. E. Dorgan, R. L. Garcea, R. T. Woodland, and R. M. Welsh. 2001. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 280:160.
74. Sirianni, M. C., R. Bonomo, B. Scarpati, S. Soddu, A. Pana, G. Turbessi, M. Cherchi, and F. Aiuti. 1986. Immunological responses of patients with recurrent herpes genitalis. Diagn. Immunol. 4:294.
75. Joncas, J., Y. Monczak, F. Ghibu, C. Alfieri, A. Bonin, G. Ahronheim, and G. Rivard. 1989. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J. Med. Virol. 28:110.
76. Jawahar, S., C. Moody, M. Chan, R. Finberg, R. Geha, and T. Chatila. 1996. Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin. Exp. Immunol. 103:408.